Lopez-Herce J, Dorao P, de la Oliva P, Delgado M A, Martinez M C, Ruza F
Paediatric Intensive Care Unit, Children's Hospital La Paz, Madrid, Spain.
Eur J Pediatr. 1989 Nov;149(2):136-7. doi: 10.1007/BF01995865.
Eight hypertensive crises (HC) were treated with 2.5 mg of sublingual nifedipine in three children with weights below 10 kg (group A); 16 HC in 6 children between 10 and 20 kg with 5 mg (group B); and 40 HC in 10 children over 20 kg with 10 mg of nifedipine (group C). The relative decrease in both systolic and diastolic blood pressure was similar in all groups. The decrease was more rapid in groups A and B when the contents were extracted from the capsule and given directly. The hypotensive effect lasted 4 h. There were no side effects. The effective and safe single dose of nifedipine has been established to be 2.5 mg for children weighing less than 10 kg, and 5 mg for children weighing between 10 and 20 kg.
对8例高血压危象(HC)患儿进行治疗,3例体重低于10 kg的儿童舌下含服2.5 mg硝苯地平(A组);6例体重在10至20 kg之间的儿童,16例高血压危象,服用5 mg(B组);10例体重超过20 kg的儿童,40例高血压危象,服用10 mg硝苯地平(C组)。所有组的收缩压和舒张压相对下降幅度相似。当从胶囊中取出内容物直接给药时,A组和B组的血压下降更快。降压作用持续4小时。未出现副作用。已确定硝苯地平的有效且安全的单剂量,体重小于10 kg的儿童为2.5 mg,体重在10至20 kg之间的儿童为5 mg。